SensiGene Fetalxy Test - Fetal Sex Determination
The new physician-ordered test, SensiGene Fetalxy, available only from Sequenom CMM, identifies genetic markers to differentiate male and female fetuses.
You can offer a highly-specific first trimester test for fetal sex determination to your patients safely and comfortably from a simple blood sample. The SensiGene Fetalxy test is powered by proprietary SEQureDx technology, which is based on thr pioneering work of Professor Dennis Lo. Through SEQureDx technology, DNA material is extracted fgrom the blood of the mother, enabling direct genetic testing to assess fetal status early in pregnancy.
Benefits of Testing Early: Know More Now!
SensiGene Fetalxy can help keep patients focused on the positive nature of their pregnancy and promotes early prenatal care. A recent consumer survey was conducted to ask women who are currently pregnant or have recently given birth their opinions on fetal sex determination. The report indicated a high interest (80%) when cost and availability are not a concern.
Benefits of the SensiGene Fetalxy test
-
Noninvasive and Safe - SensiGene Fetalxy requires only a simple blood sample from the mother. Whole Blood Collection kits are available.
-
Early Detection - determines fetal sex beginning in the first trimester.
-
Patient confidence with a physician-ordered test.
-
Highly Specific - allows the distinction between maternal and fetal DNA for both male and female fetuses
SensiGene Fetalxy Perfomance Data:
| |
|
Confidence Limits
Post Resolution (at 95%) |
| Sensitivity |
97.9% |
92.5% - 99.4% |
| Specificity |
100% |
96.9% - 100% |
Sequenom supports the ACOG Committee Opinion on Sex Selection, opposing the practice of using medical techniques to choose the sex of offspring (The American College of Obstetricians and Gynecologists (2007) “Sex Selection.” ACOG Committee Opinion, No. 360. Obstet Gynecol 109: 475-478.)
|